ID: ALA171977

Max Phase: Preclinical

Molecular Formula: C16H16N2

Molecular Weight: 236.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(Cc2nc3ccccc3[nH]2)c1C

Standard InChI:  InChI=1S/C16H16N2/c1-11-6-5-7-13(12(11)2)10-16-17-14-8-3-4-9-15(14)18-16/h3-9H,10H2,1-2H3,(H,17,18)

Standard InChI Key:  MYWFXZFJGXDAFG-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 2B1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 236.32Molecular Weight (Monoisotopic): 236.1313AlogP: 3.77#Rotatable Bonds: 2
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.25CX Basic pKa: 5.88CX LogP: 4.24CX LogD: 4.23
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.72Np Likeness Score: -1.27

References

1. Murray M, Ryan AJ, Little PJ..  (1982)  Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationships.,  25  (8): [PMID:7120277] [10.1021/jm00350a002]

Source